新型奈米 ATRA-ATO 雙藥設計及應用於非小細胞肺癌新適應症 : 從體外特性到體內評估

Design of an Advanced ATRA-ATO Nanotherapeutic Formulation to against Non-Small-Cell Lung Cancer: from In-vitro to In-vivo

游昇智(Sheng-Chih Yu)

指導教授 ： 劉典謨

國立交通大學/工學院/材料科學與工程系所/碩士(2019年)

摘要

無資料

關鍵字

雙性幾丁聚醣 ； 非小細胞肺癌 ； 合併用藥治療 ； 全反式維甲酸 ； 三氧化二砷

並列摘要

無資料

並列關鍵字

Amphiphilic chitosan ； Non-small-cell lung cancer ； Combination therapy ； All-trans retinoic acid ； Arsenic trioxide

參考文獻

1. Bray, F., et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018. 68(6): p. 394-424.

2. Chen, Q. and J. Liu, Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anticancer activity. Int J Nanomedicine, 2018. 13: p. 6009-6018.

3. Zappa, C. and S.A. Mousa, Non-small cell lung cancer: current treatment and future advances. Translational lung cancer research, 2016. 5(3): p. 288-300.

4. Huang, C.-Y., et al., A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer. BioMedicine, 2017. 7(4): p. 23-23.

5. Knight, S.B., et al., Progress and prospects of early detection in lung cancer. Open Biology, 2017. 7(9): p. 170070.